Select Publications
Journal articles
2024, 'Preferred definitive surgical management of Crohn's perianal fistulas and factors influencing surgical decision making in Australia and New Zealand', ANZ Journal of Surgery, 94, pp. 14 - 16, http://dx.doi.org/10.1111/ans.18640
,2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1818 - i1818, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1135
,2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1829 - i1829, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1142
,2024, 'P1030 Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1858 - i1859, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1160
,2024, 'P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i2023 - i2023, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1259
,2024, 'P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i657 - i657, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0416
,2024, 'P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i930 - i930, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0592
,2024, 'P529 Assessing patient-perceived burden of disease in Crohn’s disease: a novel scoring approach in a real-world Australasian cohort', Journal of Crohn's and Colitis, 18, pp. i1042 - i1044, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0659
,2024, 'P547 Improved clinical and radiologic healing of Crohn’s perianal fistulas using a novel coordinated care model optimising medical and surgical treatments: A prospective real-world observational study', Journal of Crohn's and Colitis, 18, pp. i1077 - i1078, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0677
,2024, 'P654 Assessing patient-perceived burden of disease in Ulcerative Colitis: a novel scoring approach in a real-world Australasian cohort', Journal of Crohn's and Colitis, 18, pp. i1246 - i1248, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0784
,2024, 'P854 Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis', Journal of Crohn's and Colitis, 18, pp. i1583 - i1583, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0984
,2024, 'P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1622 - i1623, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1010
,2024, 'P940 A glance into paediatric Inflammatory Bowel Disease in Australasia – Crohn’s Colitis Cure (CCC) data insights program', Journal of Crohn's and Colitis, 18, pp. i1711 - i1712, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1070
,2024, 'P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1742 - i1742, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1089
,2024, 'Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?', Inflamm Bowel Dis, http://dx.doi.org/10.1093/ibd/izad318
,2023, 'Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease', Digestive Diseases and Sciences, 68, pp. 4368 - 4380, http://dx.doi.org/10.1007/s10620-023-08146-2
,2023, 'The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform', Inflammatory Bowel Diseases, 29, pp. 1510 - 1511, http://dx.doi.org/10.1093/ibd/izad148
,2023, 'Adolescents and young adults communicating with gastroenterologists: Variation in inflammatory bowel disease clinical communication', International Journal of Adolescent Medicine and Health, 35, pp. 347 - 361, http://dx.doi.org/10.1515/ijamh-2023-0078
,2023, 'Clinician Adherence to Inflammatory Bowel Disease Guidelines: Results of a Qualitative Study of Barriers and Enablers', Crohn's and Colitis 360, 5, http://dx.doi.org/10.1093/crocol/otac018
,2023, 'Health Communication Research Informs Inflammatory Bowel Disease Practice and Research: A Narrative Review', Crohn's and Colitis 360, 5, http://dx.doi.org/10.1093/crocol/otad021
,2023, 'Letter: expanding the role for decision aids in IBD into pregnancy-related topics', Alimentary Pharmacology and Therapeutics, 58, pp. 141 - 142, http://dx.doi.org/10.1111/apt.17545
,2023, 'Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease', Digestive Diseases and Sciences, 68, pp. 889 - 896, http://dx.doi.org/10.1007/s10620-022-07556-y
,2023, 'Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial', The Lancet Gastroenterology and Hepatology, 8, pp. 215 - 227, http://dx.doi.org/10.1016/S2468-1253(22)00385-5
,2023, 'An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis', Journal of Crohn's and Colitis, 17, pp. 277 - 288, http://dx.doi.org/10.1093/ecco-jcc/jjac121
,2023, 'Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review', Pathogens, 12, http://dx.doi.org/10.3390/pathogens12020262
,2023, 'Colonic Epstein-Barr Virus-Associated Mucocutaneous Ulcer Associated With Ulcerative Colitis', ACG CASE REPORTS JOURNAL, 10, http://dx.doi.org/10.14309/crj.0000000000000978
,2023, 'P185 Global perception of normal life by healthcare professionals and IBD patients: mind the gap', Journal of Crohn's and Colitis, 17, pp. i337 - i339, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0315
,2023, 'P340 Issues on implementing treat-to-target approach in Asia Pacific, Middle East and Africa: Reality, gaps, and way forward -APMA IBD Coalition', Journal of Crohn's and Colitis, 17, pp. i476 - i478, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0470
,2023, 'P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', Journal of Crohn's and Colitis, 17, pp. i542 - i543, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0543
,2023, 'P523 Quality, safety and equity of care outcomes for inflammatory bowel disease patients at four tertiary referral centres in Australia using a cloud based management system Crohn’s Colitis Care (CCCare): A real world observational study.', Journal of Crohn's and Colitis, 17, pp. i650 - i651, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0653
,2023, 'P538 Suboptimal disease control is common in patients with Crohn’s perianal fistulas with capacity to optimise medical and surgical treatment in real-world experience: A cross-sectional analysis of baseline disease characteristics in the FINESS study', Journal of Crohn's and Colitis, 17, pp. i666 - i666, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0668
,2023, 'P550 Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years', Journal of Crohn's and Colitis, 17, pp. i678 - i680, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0680
,2023, 'Integration of mental health and quality of life screening tools in an inflammatory bowel disease-specific electronic medical record (Crohn Colitis Care): process and early outcomes', Internal Medicine Journal, 53, pp. 136 - 139, http://dx.doi.org/10.1111/imj.15989
,2023, '1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL', Gastroenterology, 164, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(23)01488-9
,2023, 'S1200 Characterization of Hospitalized Patients With Ulcerative Colitis Treated With Tofacitinib in the OCTAVE Clinical Program for up to 7.8 Years', American Journal of Gastroenterology, 118, pp. S915 - S916, http://dx.doi.org/10.14309/01.ajg.0000954440.38290.c5
,2023, 'Sa1840 SUBOPTIMAL DISEASE CONTROL IS COMMON IN PATIENTS WITH CROHN'S PERIANAL FISTULAS WITH CAPACITY TO OPTIMIZE MEDICAL AND SURGICAL TREATMENT IN REAL-WORLD EXPERIENCE: A CROSS-SECTIONAL ANALYSIS OF BASELINE DISEASE CHARACTERISTICS IN THE FINESS STUDY', Gastroenterology, 164, http://dx.doi.org/10.1016/s0016-5085(23)02054-1
,2023, 'Su1782 QUALITY, SAFETY AND EQUITY OF CARE OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS AT FOUR AUSTRALIAN TERTIARY REFERRAL CENTRES USING THE CLOUD-BASED MANAGEMENT SYSTEM CROHN'S COLITIS CARE (CCCARE) : A REAL WORLD OBSERVATIONAL STUDY', Gastroenterology, 164, pp. S - 679, http://dx.doi.org/10.1016/s0016-5085(23)02580-5
,2022, 'Safety, satisfaction and cost savings of accelerated infusions of standard and intensified-dose infliximab for inflammatory bowel disease', Internal Medicine Journal, 52, pp. 2143 - 2149, http://dx.doi.org/10.1111/imj.15493
,2022, 'Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children', Journal of Crohn's and Colitis, 16, pp. 1835 - 1844, http://dx.doi.org/10.1093/ecco-jcc/jjac093
,2022, 'Extra-mammary Paget's disease rising from a non-invasive rectal adenoma', Pathology, 54, pp. 826 - 828, http://dx.doi.org/10.1016/j.pathol.2021.11.011
,2022, 'A Novel Decision Aid Improves Quality of Reproductive Decision-Making and Pregnancy Knowledge for Women with Inflammatory Bowel Disease', Digestive Diseases and Sciences, 67, pp. 4303 - 4314, http://dx.doi.org/10.1007/s10620-022-07494-9
,2022, 'Survey of barriers to adherence to international inflammatory bowel disease guidelines: does gastroenterologists' confidence translate to high adherence?', Internal Medicine Journal, 52, pp. 1330 - 1338, http://dx.doi.org/10.1111/imj.15299
,2022, 'Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease', World Journal of Gastroenterology, 28, pp. 2597 - 2608, http://dx.doi.org/10.3748/wjg.v28.i23.2597
,2022, 'Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas', Clinical Gastroenterology and Hepatology, 20, pp. 1306 - 1314, http://dx.doi.org/10.1016/j.cgh.2021.07.053
,2021, 'Menetrier's disease exacerbating ulcerative colitis and relieved by gastrectomy', BMJ Open Gastroenterology, 8, http://dx.doi.org/10.1136/bmjgast-2021-000806
,2021, 'Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid', BMC Gastroenterology, 21, http://dx.doi.org/10.1186/s12876-021-01853-y
,2021, 'The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: An Australian study', European Journal of Gastroenterology and Hepatology, 33, pp. E771 - E776, http://dx.doi.org/10.1097/MEG.0000000000002249
,2021, 'Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living with Ulcerative Colitis-Patients' and Physicians' View', Inflammatory Bowel Diseases, 27, pp. 1747 - 1755, http://dx.doi.org/10.1093/ibd/izab016
,2021, 'Ulcerative Colitis Narrative findings: Australian survey data comparing patient and physician disease management views', JGH Open, 5, pp. 1033 - 1040, http://dx.doi.org/10.1002/jgh3.12627
,2021, 'Clinical communication in inflammatory bowel disease: A systematic review of the study of clinician-patient dialogue to inform research and practice', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2021-051053
,